rHSV-1-APD1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamerHSV-1-APD1
Drug Alias NamePD-1 checkpoint inhibitor (YST Group/Xiamen University)Recombinant Human PD-1 mAb Herpes Simplex Virus Type 1 (YST Group/Xiamen University)YST-02
ClassificationBiologics > Oncolytic virusBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursCentral Nervous System NeoplasmsGlioma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesXiamen University
China Registration ClassN/A

Develop Information

Active CompaniesYST GroupXiamen University
Inactive CompaniesN/A
Active IndicationsSolid tumoursCentral Nervous System NeoplasmsGlioma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A